Open AccessPrevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
Author(s) -
Gitanjali Goyal,
Kmds Panag,
Ravinder Garg
Publication year - 2016
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/2229-516x.192587
Subject(s) - medicine , ribavirin , euthyroid , thyroid , hepatitis c virus , gastroenterology , hepatitis c , interferon , alpha interferon , antiviral therapy , immunology , virus , chronic hepatitis
Hepatitis C virus (HCV) infection is common worldwide. The treatment typically involves a combination of interferon-alpha (IFN-α) and ribavirin (RBV) therapy; however, the use of IFN-α is well documented to be associated with thyroid disease, the most common autoimmune disorder associated with IFN-α.